Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19

Completed

• Conditions: Covid19
• Interventions: Other: Respiratory functions

• Registration Number: NCT04789512
• Lead Sponsor: Gazi University

Brief Summary

In literature, there is no data evaluating respiratory functions in volleyball players during Covid-19 pandemic. The aim of this study is to evaluate and compared pulmonary functions, respiratory muscle strength, body compositions and performance situations perceptions in female volleyball players with Covid-19 and non-Covid-19.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-03
• Study Start: 2021-03-01
• Study First Submitted: 2021-03-06
• Study First Submitted QC: 2021-03-08
• Study First Posted: 2021-03-09
• Primary Completion: 2021-03-26
• Study Completion: 2021-03-29
• Last Update Submitted: 2021-03-29
• Last Update Posted: 2021-04-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 42

Inclusion Criteria

• having passed at least 30 days after the Polymerase Chain Reaction (PCR) test turned negative
• willing to participate in the study

Exclusion Criteria

• having a history of chronic lung disease
• unwilling to participate in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Covid-19 players	Respiratory functions	Female volleyball players with Covid-19
non-Covid-19 players	Respiratory functions	Female volleyball players with non Covid-19

Primary Outcome Measures

Name	Time	Method
Respiratory muscle strength	10 minute	Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device.

Secondary Outcome Measures

Name	Time	Method
FEV1	5 minute	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1 will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal.
FVC	5 minute	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FVC will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal
FEV1/FVC	5 minute	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1/FVC will be evaluated.
PEF	5 minute	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. PEF will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal.
FEF2575	5 minute	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value \<50% will be expressed as abnormal.
Fat mass	2 minute	Fat mass will be evaluated using TANITA bioelectrical impedance analysis.
Fat mass percent	2 minute	Fat mass percent will be evaluated using TANITA bioelectrical impedance analysis.
Fat-free mass	2 minute	Fat-free mass will be evaluated using TANITA bioelectrical impedance analysis.
Body mass index	2 minute	Body mass index will be evaluated using TANITA bioelectrical impedance analysis.
Predicted muscle mass	2 minute	Predicted muscle mass will be evaluated using TANITA bioelectrical impedance analysis.
Symptom severity perceptions	1 minute	Symptom severity perceptions will be evaluated Numeric Rating Scale.The severity of symptoms perceptions related to Covid are scored 0-10 point. Higher scores indicate higher severity of symptoms.
Performance situations perceptions	1 minute	Performance situations perceptions will be evaluated Numeric Rating Scale. Performance situations perceptions of all players are also scored 0-10 point. Higher scores indicate greater performance.

Trial Locations

Locations (1)

Gazi University; 🇹🇷 Ankara, Çankaya, Turkey